Investment / Co-development Opportunity for Start-up Company
Variant Specific Periostin Neutralization for Diabetic Retinopathy
A new therapeutic mechanism to inhibit cytokine production from topical IL-17-producing cells by CD9…
Treatment of immunological diseases by a new mechanism to control the immune Th1/Th2 balance
New therapeutic targets and therapeutic agents for trauma-induced heterotopic ossification in FOP pa…
Cell Surface Antigen CD48 as A Novel Molecular Target for Antibody Therapy in Multiple Myeloma
Selective inhibition of Periostin variant (PN1) by monoclonal antibody
CHRNB2, a novel target for gastric cancer, potentially other tumors
Improvement of cilial dysfunction by FGFR inhibitor through ICK/MAK pathway activation.
A novel therapeutic approach for systemic anti-tumor immunity utilizing apolipoproteins